Irish firm Neuromod raises €30m in plan to target anti-tinnitus device at US veterans

Company is aiming to commercialise its product, which treats ringing in the ears by delivering mild electrical pulses to the tongue coupled with auditory stimulation

Ross O’Neill: the chief executive of Neuromod said the company was aiming to address a paucity of innovation in tinnitus treatment

Neuromod, the Irish medical technology firm, has raised €30 million in new financing to fund the launch of its tinnitus treatment device in the US, Italy, Portugal and Sweden.

The Dublin-headquartered firm has secured a €15 million expansion of a previous Series B funding round, as well as €15 million in venture debt from the European Investment Bank (EIB), as it seeks to improve the treatment of a hearing condition that impacts 10 to 15 ...